Baird Maintains Outperform on Intuitive Surgical, Raises Price Target to $503
Piper Sandler Remains a Buy on Intuitive Surgical (ISRG)
Morgan Stanley Adjusts Price Target on Intuitive Surgical to $475 From $460, Maintains Equalweight Rating
Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), Nuvation Bio (NUVB)
Strong Performance and Growth Prospects Underpin Buy Rating for Intuitive Surgical
Meta Platforms Analyst Ratings
Oppenheimer Adjusts Price Target on Meta Platforms to $525 From $500, Maintains Outperform Rating
New Street Adjusts Price Target on Alphabet to $210 From $200, Maintains Buy Rating
Intuitive Surgical Analyst Ratings
Deutsche Bank Adjusts Price Target on Meta Platforms to $525 From $500
Mizuho Adjusts Price Target on Alphabet to $205 From $190, Maintains Outperform Rating
Barclays Remains a Buy on Intuitive Surgical (ISRG)
New Buy Rating for Intel (INTC), the Technology Giant
Alphabet Analyst Ratings
BMO Capital Adjusts Price Target on Alphabet to $222 From $215, Maintains Outperform Rating
Qualcomm Analyst Ratings
Wolfe Research Keeps Their Buy Rating on Alphabet Class A (GOOGL)
Intel Analyst Ratings
Argus Research Maintains Buy on Alphabet, Raises Price Target to $215
Baird Adjusts Price Target on Intuitive Surgical to $487 From $436, Maintains Outperform Rating